M
Matthew E. Oster
Researcher at Emory University
Publications - 211
Citations - 9486
Matthew E. Oster is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 36, co-authored 156 publications receiving 5030 citations. Previous affiliations of Matthew E. Oster include Centers for Disease Control and Prevention & University of South Florida.
Papers
More filters
Journal ArticleDOI
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.
Leora R. Feldstein,Leora R. Feldstein,Erica B. Rose,Erica B. Rose,Steven M. Horwitz,Jennifer P. Collins,Margaret M Newhams,Mary Beth F. Son,Jane W. Newburger,Lawrence C. Kleinman,Sabrina M. Heidemann,Amarilis A. Martin,Aalok R. Singh,Simon Li,Keiko M. Tarquinio,Preeti Jaggi,Matthew E. Oster,Sheemon P. Zackai,Jennifer K. Gillen,Adam J. Ratner,Rowan Walsh,Julie C. Fitzgerald,Michael A. Keenaghan,Hussam Alharash,Sule Doymaz,Katharine N. Clouser,John S. Giuliano,Anjali Gupta,Robert M. Parker,Aline B Maddux,Vinod Havalad,Stacy Ramsingh,Hulya Bukulmez,Tamara T. Bradford,Lincoln S. Smith,Mark W Tenforde,Christopher L. Carroll,Becky J. Riggs,Shira J. Gertz,Ariel Daube,Amanda N Lansell,Alvaro Coronado Munoz,Charlotte V. Hobbs,Kimberly Marohn,Natasha B. Halasa,Manish M. Patel,Manish M. Patel,Adrienne G. Randolph +47 more
TL;DR: Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents.
Journal ArticleDOI
COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.
Shana Godfred-Cato,Bobbi Bryant,Jessica Leung,Matthew E. Oster,Laura Conklin,Joseph Y. Abrams,Katherine Roguski,Bailey Wallace,Emily Prezzato,Emilia H. Koumans,Ellen H. Lee,Anita Geevarughese,Maura K. Lash,Kathleen H. Reilly,Wendy P Pulver,Deepam Thomas,Kenneth A. Feder,Katherine K. Hsu,Nottasorn Plipat,Gillian Richardson,Heather Reid,Sarah Lim,Ann Schmitz,Timmy Pierce,Susan Hrapcak,Deblina Datta,Sapna Bamrah Morris,Kevin R. Clarke,Ermias D. Belay +28 more
TL;DR: As the COVID-19 pandemic continues to expand in many jurisdictions, clinicians should be aware of the signs and symptoms of MIS-C and report suspected cases to their state or local health departments; analysis of reported cases can enhance understanding of MIS -C and improve characterization of the illness for early detection and treatment.
Journal ArticleDOI
Temporal Trends in Survival Among Infants With Critical Congenital Heart Defects
Matthew E. Oster,Matthew E. Oster,Kyung A. Lee,Margaret A. Honein,Tiffany Riehle-Colarusso,Mikyong Shin,Adolfo Correa,Adolfo Correa +7 more
TL;DR: One- year survival for infants with CCHDs has been improving over time, yet mortality remains high, and later diagnosis is associated with improved 1-year survival.
Journal ArticleDOI
Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010.
Suzanne M. Gilboa,Owen Devine,James E. Kucik,Matthew E. Oster,Tiffany Riehle-Colarusso,Wendy N. Nembhard,Ping Xu,Adolfo Correa,Kathy J. Jenkins,Ariane Marelli +9 more
TL;DR: The estimates highlight the need for planning for health services delivery to meet the needs of the growing population of adults with CHD and the development of surveillance data across the life span to provide empirical estimates of the prevalence of CHD across all age groups in the United States.
Journal ArticleDOI
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
Matthew E. Oster,David K. Shay,John R. Su,Julianne Gee,C. Buddy Creech,Karen R. Broder,Kathryn M. Edwards,Jonathan H. Soslow,Jeffrey M Dendy,Elizabeth P. Schlaudecker,Sean M. Lang,Elizabeth D. Barnett,Frederick L. Ruberg,M. Smith,Michael J. Campbell,Renato D. Lopes,Laurence S. Sperling,Jane A Gwira Baumblatt,Deborah Thompson,Paige Marquez,Penelope Strid,Jared Woo,River A. Pugsley,Sarah Reagan-Steiner,Frank DeStefano,Tom T. Shimabukuro +25 more
TL;DR: The risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men.